Cargando…
SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation
Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) infects cells through interaction of its spike protein (SARS2-S) with angiotensin-converting enzyme 2 (ACE2) and activation by proteases, in particular transmembrane protease serine 2 (TMPRSS2). Viruses can also spread through fusi...
Autores principales: | Hörnich, Bojan F., Großkopf, Anna K., Schlagowski, Sarah, Tenbusch, Matthias, Kleine-Weber, Hannah, Neipel, Frank, Stahl-Hennig, Christiane, Hahn, Alexander S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104116/ https://www.ncbi.nlm.nih.gov/pubmed/33608407 http://dx.doi.org/10.1128/JVI.00002-21 |
Ejemplares similares
-
Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV
por: Lokugamage, Kumari G., et al.
Publicado: (2020) -
Spike Glycoprotein and Host Cell Determinants of SARS-CoV-2 Entry and Cytopathic Effects
por: Nguyen, Hanh T., et al.
Publicado: (2021) -
The “LLQY” Motif on SARS-CoV-2 Spike Protein Affects S Incorporation into Virus Particles
por: Du, Shouwen, et al.
Publicado: (2022) -
SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog
por: Chen, Jiyao, et al.
Publicado: (2022) -
Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition
por: Navaratnarajah, Chanakha K., et al.
Publicado: (2021)